Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-151381 |
Brand: | MCE |
CAS: | 3033087-05-4 |
MDL | - |
---|---|
Molecular Weight | 470.80 |
Molecular Formula | C21H15ClF4N2O4 |
SMILES | C/C(O)=C(C(NC1=C(C=C(C(O[C@H](C(F)(F)F)C)=C1)C(C2=C(C=CC=C2)Cl)=O)F)=O)\C#N |
hDHODH-IN-10 is a selective, potent and orally active hDHODH inhibitor, with an IC 50 value of 10.9 nM. hDHODH-IN-10 forms hydrogen bonds with key residues Arg136 and Gln47. hDHODH-IN-10 inhibits the proliferation of cancer cells. hDHODH-IN-10 can be used in the research of cancers, such as AML, colorectal cancer [1] .
IC50: hDHODH (10.9 nM) [1] .
hDHODH-IN-10 (compound 7d, 1 nM-100 μM) displays anti-proliferative activities against multiple human cancer cells
[1]
.
hDHODH-IN-10 (0.0625-0.25 μM, 24 h) increases the percentage of S-phase cells in Raji and HCT116 cells
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | U937, HCT116, A375, Kasumi-1 and KG-1 cells |
Concentration: | 0-10 μM approximately |
Incubation Time: | 96 h |
Result: | Inhibits cell proliferation with IC 50 values of 0.1-0.8 μM. |
Cell Cycle Analysis [1]
Cell Line: | Raji and HCT116 cells |
Concentration: | 0.0625, 0.125 and 0.25 μM |
Incubation Time: | 24 h |
Result: | Increased the percentage of S-phase cells from 42.8% to 54.2%, 60.6% and 67.1%, respectively. |
hDHODH-IN-10 (compound 7d, 30 mg/kg, oral administration) inhibits tumor growth in Raji and HCT116 cells xenograft mice model
[1]
.
hDHODH-IN-10 (500 mg/kg, oral administration) exhibits a favorable safety profile
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Raji and HCT116 cells xenograft mice model [1] |
Dosage: | 30 mg/kg |
Administration: | Oral administration |
Result: | Showed a tumor growth inhibitory (TGI) rate of 58.3% (Raji model) and 42.1% (HCT116 model). |
Animal Model: | BALB/c mice (acute toxicity assay) [1] |
Dosage: | 500 mg/kg |
Administration: | Oral administration |
Result: |
LD
50
is about 500 mg/kg.
Induced a weak dysfunction of liver. |
Room temperature in continental US; may vary elsewhere.
Please store the product under the recommended conditions in the Certificate of Analysis.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.